Navigation Links
Evidence for omega 3 fats less conclusive than we thought, say experts

A study published online by the BMJ today doesn't find evidence of a clear benefit of omega 3 fats on health.

These findings do not rule out an important effect of omega 3 fats, but suggest that the evidence should be reviewed regularly, say the researchers.

Consumption of long chain omega 3 fatty acids, found in oily fish and fish oils, and a shorter chain omega 3, found in some plant oils, is thought to protect against heart disease. UK guidelines encourage the general public to eat more oily fish, and higher amounts are advised after a heart attack.

Researchers analysed 89 studies (48 randomised controlled trials and 41 cohort studies) to assess the health effects of long and short chain omega 3 fats on total mortality, cardiovascular events, cancer, and strokes.

Each study involved a treatment group and a control group and investigated the effect of omega 3 intake on health for at least six months. Differences in study quality were taken into account to identify and minimise bias.

Pooling the results showed no strong evidence that omega 3 fats have an effect on total mortality or combined cardiovascular events. The few studies at low risk of bias were more consistent, but they also showed no effect of omega 3 on total mortality or cardiovascular events.

When data on long chain omega 3 fats were analysed separately, total mortality and cardiovascular events were not reduced. No study showed increased risk of cancer or stroke with higher intake of omega 3, but there were too few events to rule out important effects.

Other recent reviews of omega 3 trials found that omega 3 fats decrease mortality, but the publication of a large contradictory trial has changed the overall picture. The authors cannot say exactly why the results of this trial differ from the other large studies in this field.

They therefore conclude that it is not clear whether long chain or short chain omega 3 fats (together or separat ely) reduce or increase total mortality, cardiovascular events, cancer, or strokes.

UK guidelines advising people to eat more oily fish should continue at present but the evidence should be reviewed regularly, say the authors. However, it is probably not appropriate to recommend a high intake of omega 3 fats for people who have angina but have not had a heart attack.

To understand the effects of omega 3 fats on health, we need more high quality randomised controlled trials of long duration that also report the associated harms, they conclude.

We are faced with a paradox, says Eric Brunner in an accompanying editorial. Health recommendations advise increased consumption of oily fish and fish oils. However, industrial fishing has depleted the world's fish stocks by some 90% since 1950, and rising fish prices reduce affordability particularly for people with low incomes.

Global production trends suggest that, although fish farming is expanding rapidly, we probably do not have a sustainable supply of long chain omega 3 fats, he warns.


'"/>

Source:BMJ-British Medical Journal


Related biology news :

1. Evidence of 600-million-year old fungi-algae symbiosis discovered in marine fossils
2. Researchers create pigs that produce heart-healthy omega-3 fatty acids
3. Innovative method for creating a human cytomegalovirus vaccine outlined
4. LIAI scientists make important finding on cytomegalovirus transmission
5. DNA conclusive yet still controversial, Carnegie Mellon professor says
6. Oceans more vulnerable to agricultural runoff than previously thought, study finds
7. Katrina floodwaters not as toxic to humans as previously thought, study says
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/13/2018)... SAN FRANCISCO (PRWEB) , ... December 13, 2018 ... ... life sciences, just released a must-see documentary entitled “What Researchers Need to ... Biocompare’s Reproducibility Issues in Life Science Research series. The goal of this film ...
(Date:12/10/2018)... ... December 10, 2018 , ... Today, ... advance their shared goal of accelerating the development of the Regenerative Medicine field. ... to TRT’s core technology around human umbilical cord perivascular cells (HUCPVCs). Together, ...
(Date:12/5/2018)... ... December 05, 2018 , ... Surgical Theater brings familial patient ... December 6-9, 2018 at booth #312. AANS/CNS provides Pediatric Neurosurgeons an opportunity to ... continuum – from the consultation, to surgical planning, and into the operating room. ...
Breaking Biology News(10 mins):
(Date:12/13/2018)... ... ... Helping conclude Healthy Aging Month this past September, Signia partners with Mediaplanet ... and Hearing campaign that sets out to shed light on various ways to help ... destigmatize hearing aids over the years, 9 out of 10 people with mild to ...
(Date:12/10/2018)... ... December 10, 2018 , ... ... Development and Manufacturing Organization (CDMO) with sites in China and the United ... and aseptic fill finish solutions for monoclonal antibody (mAb) and antibody-drug conjugate ...
(Date:12/5/2018)... ... December 05, 2018 , ... The incredible life story of former refugee ... European Parliament by Carlos Moedas, the European Commissioner for Research and Innovation. , ... Our Daily Lives, Commissioner Moedas spoke at length of Yousef’s life and journey, citing ...
(Date:12/5/2018)... ... December 04, 2018 , ... ... North American full-service contract research organization (CRO), announced the acquisition of CCA ... strengthens ARG’s reach and experience in the management of clinical trials. , ...
Breaking Biology Technology: